Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

LD-2 disclosure · 2nd Quarter - Report

AMERISOURCEBERGEN

via EFB ADVOCACY, LLC

2nd Quarter (Apr 1 - June 30) · 2020Posted Jul 17, 2020Filing document ↗LDA record ↗

Income$30Kfee reported

Client

Name: AMERISOURCEBERGEN
Description: Distribution of Pharmaceuticals
Location: District of Columbia · United States of America

Registrant

Firm: EFB ADVOCACY, LLC
Description: Lobbying & consulting
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
Healthcare Distribution Issues
LobbyistsJOHN EASTON · JOHN PATRICK FEEHERY
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

AMERISOURCEBERGEN — Lobbying — Receipts Report